167 related articles for article (PubMed ID: 2042062)
1. Chemotherapy of ovarian cancer.
Ozols RF; Young RC
Semin Oncol; 1991 Jun; 18(3):222-32. PubMed ID: 2042062
[No Abstract] [Full Text] [Related]
2. [Standard of chemotherapy in ovarian cancer].
Pfleiderer A; Meerpohl HG
Chirurg; 1994 Jan; 65(1):18-22. PubMed ID: 8149794
[No Abstract] [Full Text] [Related]
3. [Is there a standard therapy in advanced ovarian carcinoma?].
Köchli OR
Praxis (Bern 1994); 1999 Jan; 88(4):123-5. PubMed ID: 10067114
[No Abstract] [Full Text] [Related]
4. Early versus delayed treatment of relapsed ovarian cancer.
Rustin G; van der Burg M; Griffin C; Qian W; Swart AM
Lancet; 2011 Jan; 377(9763):380-1. PubMed ID: 21277438
[No Abstract] [Full Text] [Related]
5. Current aspects of adjuvant therapy of early stage ovarian cancer.
McGuire WP
Zentralbl Gynakol; 1998; 120(3):93-7. PubMed ID: 9556898
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy and prognostic significance of the size of the remaining tumor in ovarian cancer].
Petru E; Lahousen M; Pickel H; Stettner H
Gynakol Rundsch; 1989; 29 Suppl 2():413-4. PubMed ID: 2613067
[No Abstract] [Full Text] [Related]
7. [Ovarian cancer from the standpoint of medical oncology].
Kato Y; Katsumata N
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1017-21. PubMed ID: 17637538
[TBL] [Abstract][Full Text] [Related]
8. Does secondary surgical cytoreduction improve survival in women with advanced ovarian cancer?
Munkarah A
Nat Clin Pract Oncol; 2005 Apr; 2(4):188-9. PubMed ID: 16264930
[No Abstract] [Full Text] [Related]
9. The effect of surgical debulking on the response of patients with ovarian carcinoma to chemotherapy.
McDermott DF; Jaffe EA; Coleman M; Pasmantier MW
Am J Clin Oncol; 1988 Oct; 11(5):520-3. PubMed ID: 3177252
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of platinum-resistant ovarian cancer].
Onishi Y; Nakamura T; Hatae M
Nihon Rinsho; 2004 Oct; 62 Suppl 10():554-9. PubMed ID: 15535307
[No Abstract] [Full Text] [Related]
11. Chemotherapy for ovarian cancer: an evidence-based approach.
Geisler JP; Manahan KJ; Wiemann MC
Minerva Ginecol; 2004 Dec; 56(6):539-45. PubMed ID: 15729206
[TBL] [Abstract][Full Text] [Related]
12. Nursing procedures for intraperitoneal administration of cis-platin and Ara-C in the community hospital.
Olson EZ; Selders NJ
Prog Clin Biol Res; 1986; 216():367-75. PubMed ID: 3725800
[No Abstract] [Full Text] [Related]
13. Specialized surgery in ovarian cancer.
Piver MS
Eur J Cancer Clin Oncol; 1987 Feb; 23(2):123-5. PubMed ID: 3443134
[No Abstract] [Full Text] [Related]
14. Metastatic Sertoli-Leydig cell ovarian cancer manifested as a frontal sinus mass.
Campisi P; Cheski P
J Otolaryngol; 1998 Dec; 27(6):361-2. PubMed ID: 9857323
[No Abstract] [Full Text] [Related]
15. Treatment of gynecologic cancer: the US experience.
Ozols R
Tumori; 1999; 85(3 Suppl 1):S5-11. PubMed ID: 10542879
[No Abstract] [Full Text] [Related]
16. Chemotherapy in epithelial ovarian cancer.
Wang J; Li AJ; Karlan BY
Curr Womens Health Rep; 2002 Feb; 2(1):20-6. PubMed ID: 12112979
[TBL] [Abstract][Full Text] [Related]
17. [Personal experiences in the treatment of stage III and IV ovarian cancer].
Welponer F; Delucca A; Messini S
Gynakol Rundsch; 1990; 30 Suppl 1():45-8. PubMed ID: 2079298
[No Abstract] [Full Text] [Related]
18. High-dose chemotherapy and hematopoietic progenitor cell support for patients with epithelial ovarian cancer.
Kotz KW; Schilder RJ
Semin Oncol; 1995 Jun; 22(3):250-62. PubMed ID: 7777869
[No Abstract] [Full Text] [Related]
19. [Combination therapy with irinotecan and CBDCA for patients in terminal stage of ovarian carcinoma].
Kajino T; Higuchi M; Hata K; Shibata N
Gan To Kagaku Ryoho; 1996 Jan; 23(1):115-7. PubMed ID: 8546461
[TBL] [Abstract][Full Text] [Related]
20. [The treatment of refractory ovarian cancer].
Shparyk IaV; Tomych MV
Lik Sprava; 1996; (10-12):41-7. PubMed ID: 9138811
[No Abstract] [Full Text] [Related]
[Next] [New Search]
